Transrectal ultrasound (TRUS)-guided needle biopsy is routinely performed to diagnose and stage prostate carcinoma in an outpatient setting. Although serious adverse effects are rare, minor complications are common. We report the occurrence of an acute periprostatic haematoma as an unusual complication of TRUS-guided needle-biopsy of the prostate, resulting in the patient requiring prompt resuscitation and hospital admission.
Introduction
Transrectal ultrasound (TRUS)-guided needle biopsy of the prostate is the method of choice for detecting prostate cancer as it safely allows early detection of the tumour. Although patient acceptance and tolerance of this procedure is high, 1 there is a significant side effect profile with 64 -78% of patients experiencing at least one complication, 2,3 most of which are minor and do not require hospital admission. Bleeding is the commonest complication following TRUS-guided needle biopsy of the prostate but is usually limited to transient haematuria, haematospermia and rectal bleeding, 1 therefore not requiring active treatment. Major adverse effects following this procedure are rare. Sepsis is undoubtedly the most serious complication and in some patients is life-threatening.
We report on an unusual case of acute periprostatic bleeding and haematoma formation requiring prompt resuscitation, hospitalisation and close follow-up subsequent to TRUS-guided needle biopsy of the prostate.
Case report
A 64-y-old man presented with lower urinary tract symptoms. On examination, a smooth 50-gram prostate was felt. An ultrasound showed he had normal upper urinary tracts but a post-void residual volume of 400 mls with a reduced urine flow rate at 6.7 mls/s. The electrolytes were within normal range but the PSA was elevated at 9.2 ng/ml. TRUS showed no suspicious areas and sextant biopsies were performed under sedation and appropriate antibiotic cover.
One hour following the procedure the patient developed severe perineal pain, bradycardia and hypotension requiring prompt resuscitation. Digital rectal examination revealed no bleeding and ECG and bloods were normal. Due to progressive difficulty in voiding, the patient was catheterised. Two hours later bruising in the perianal and bulbar urethral tissues developed (Figure 1 ). The following day his haemoglobin dropped by 1 g/dl and TRUS showed a large haematoma between the prostate and rectal wall (Figure 2 ). Over the following 2 weeks there were two further episodes of retention and the haematoma and bruising gradually resolved. Histology of the prostatic biopsies confirmed benign prostatic hyperplasia (BPH).
Comment
TRUS-guided needle biopsy is the optimum method for diagnosing prostate cancer and is a commonly performed outpatient or day case procedure. However, it can be associated with several adverse effects, 4 most are minor not requiring hospitalisation.
Bleeding is the commonest complication following TRUS-guided needle biopsy. In a study by Rodriguez et al 47.1% of cases reported persistent haematuria. 3 In another study by Deliveliotis et al 65% of patients developed haematuria, 33.3% had blood in the stool and 29.1% had haematospermia. 5 Similar results have been seen in other series. 1, 6, 7 In all cases bleeding was transient and did not require hospital admission.
A similar complication to the one observed in our unit, has been reported once before following trucut biopsy of the prostate; however, selective intra-arterial embolisation was consequently required to control further bleeding. 8 A severe periprostatic bleed such as our case demonstrates, is a rare but important complication of TRUS-guided needle biopsy of the prostate and should be suspected in patients suffering a fall in blood pressure and/or subsequent perineal bruising post-procedure. In all cases early recognition and intervention are necessary in avoiding major morbidity and mortality. 
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